Related Experiment Video
Updated: Apr 3, 2026

Author Spotlight: A Novel Standardized Technique for Real-Time Biomedical Imaging of Acute Myocardial Injury
Published on: March 22, 2024
Complex Coronary Interventions with the Novel Mozec™ CTO Balloon: The MOZART Registry
Alessandro Lupi1, Andrea Rognoni1, Alon Schaffer2
12nd Division of Cardiology, "Maggiore della Carità" Hospital, Novara, Italy.
Insights
The novel Mozec™ CTO balloon catheter effectively treats complex coronary lesions, including chronic total occlusions (CTOs), with high success rates. This device shows promise for complex lesion interventions in an all-comers population.
Area of Science:
- Interventional Cardiology
- Medical Device Technology
- Vascular Surgery
Background:
- The Mozec™ CTO is a new balloon catheter designed for complex coronary lesions like chronic total occlusions (CTOs).
- Limited data exist on its performance in a diverse patient group with complex coronary artery disease.
Purpose of the Study:
- To evaluate the safety and success rate of the Mozec™ CTO balloon catheter.
- To assess its performance in an all-comers population with complex coronary lesions.
Main Methods:
- The study included 41 consecutive patients with complex coronary lesions.
- Lesion types comprised severe calcified stenoses, bifurcation lesions, and CTOs.
- Safety was measured by balloon burst rate; success was defined as device advancement past the lesion.
Main Results:
- High success rates were observed: 93.3% for calcified lesions, 93.3% for bifurcations, and 90.9% for CTOs.
- Low balloon burst rates were reported across all lesion types.
- The device successfully crossed challenging calcified and CTO lesions.
Conclusions:
- The Mozec™ CTO balloon catheter demonstrates promising results for treating complex coronary lesions.
- It may offer a cost-effective alternative to specialized devices like over-the-wire balloons and microcatheters.
Background:
Mozec™ CTO is a novel semicompliant rapid-exchange PTCA balloon catheter with specific features dedicated to treat complex coronary lesions like chronic total occlusions (CTOs). However, no data have been reported about the performance of this device in an all-comers population with complex coronary lesions.
Methods:
We evaluated the safety and success rate of Mozec™ CTO balloon in 41 consecutive patients with chronic stable angina and complex coronary lesions (15 severe calcified coronary stenoses, 15 bifurcation lesions with planned two-stent intervention, and 11 CTOs). Safety was assessed reporting the balloon burst rate after inflation exceeding the rated burst pressure (RBP) according to the manufacturer's reference table. Success was defined as the possibility to advance the device further the target lesion.
Results:
The Mozec™ CTO balloon showed an excellent performance with a 93.3% success in crossing tight and severely calcified lesions (14/15 pts), a 93.3% success in engaging jailed side branches after stent deployment across bifurcations (14/15 pts), and a 90.9% success in crossing CTO lesions (10/11 pts). The burst rate at RBP of the Mozec™ CTO balloon was 6.7% (1/15 balloons) in the tight and severely calcified lesions, 6.7% (1/15 balloons) when dilating jailed vessels, and 9.1% (1/11 balloons) in CTOs.
Conclusions:
The novel Mozec™ CTO balloon dilatation catheter showed promising results when employed to treat complex lesions in an all-comers population. Further studies should clarify if this kind of balloon might reduce the need of more costly devices like over-the-wire balloons and microcatheters for complex lesions treatment.
Related Concept Videos
Mitral Stenosis III: Medical Management
Cardiac Catheterization II: Right Heart Catheterization
Cardiac Catheterization III: Left Heart Catheterization
Coronary Artery Disease I: Introduction
Coronary Circulation
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...
Mitral Regurgitation III: Medical Management

